News
53m
Stockhead on MSNHealth Check: Tetratherix breaks biotech IPO drought with 13pc gain on debutTetratherix today has listed at a solid premium to its IPO price, raising the hopes of other life science outfits ... Read ...
Its the final trading day of the week, the second-last trading day of the month and for the April-June quarter as well. The ...
The execution is spread out and will run through two fiscal years starting in FY 2025–26 and continuing into FY 2026–27.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results